Double-blind, randomized clinical trial of troxerutin-carbazochrome in patients with hemorrhoids.

Abstract

This multicenter, double-blind, randomised study was undertaken to determine the efficacy and safety of a combination of troxerutin 150 mg and carbazochrome 1.5 mg compared to carbazochrome alone in patients with acute uncomplicated hemorrhoids. Patients were administered by the intramuscular route (one ampoule) twice daily for one week. Both subjective and objective efficacy variables significantly improved in the combination drug group only, thus demonstrating the rationale for a combination therapy. Treatments were safe and well tolerated either at a local or systemic level.

• Authors: F Squadrito, D Altavilla, S Oliaro Bosso
• Journal: European review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) 2000 Jan-Apr Vol. 4 Issue 1-2 Pg. 21-4 ISSN: 1128-3602 [Print] Italy
• PMID: 11409185 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Drug Combinations
• Hemostatics
• Hydroxyethylrutoside
• Vasoconstrictor Agents
• Adrenochrome
• troxerutin
• carbazochrome

Topics

• Adrenochrome (administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
• Adult
• Double-Blind Method
• Drug Combinations
• Female
• Hemorrhoids (drug therapy)
• Hemostatics (administration & dosage, adverse effects, therapeutic use)
• Humans
• Hydroxyethylrutoside (administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
• Male
• Vasoconstrictor Agents (administration & dosage, adverse effects, therapeutic use)